Efficiency of liposomal doxorubicin in the treatment of advanced breast cancer after completed conventional doxorubicin cumulative dose

Abstract

Liposomal doxorubicin is indicated for the treatment of advanced breast cancer. In combination with cyclophosphamide is an effective alternative in first-line treatment. However, it can also be successfully used in subsequent lines of chemotherapy. This paper presents a case study of patient treated with the above regimen in the third-line therapy, after exceeding the cumulative dose of classic doxorubicin.
Onkol. Prak. Klin. 2010; supl. A: A37–A39